These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Verrica Pharmaceuticals (VRCA), 658% surge in interest Macrogenics (MGNX),
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Verrica Pharmaceuticals (VRCA), 658% surge in interest Macrogenics (MGNX),
JMP Securities analyst Silvan Tuerkcan downgraded MacroGenics (MGNX) to Market Perform from Outperform without a price target The company “is in a holding pattern” with respect to its pipeline, has
סילבן טורקאן, אנליסט ב-JMP Securities, הוריד את MacroGenics (MGNX) לדירוג החזקה משוק מקנייה, ללא קביעת מחיר יעד. החברה אינה מתקדמת כרגע בפיתוח המוצרים שלה, הפסיקה את כל העבודה על vobra
MacroGenics (MGNX – Research Report) received a Hold rating and price target from JMP Securities analyst Silvan Tuerkcan yesterday. The company’s shares closed yesterday at $4.19. Tuerkcan covers the Healthcare
B.Riley Financial analyst Mayank Mamtani has maintained their neutral stance on MGNX stock, giving a Hold rating today. Mayank Mamtani’s rating is based on MacroGenics’ ongoing transition in both its